U-Blot® Research Grade Anti-Human CD85k/LILRB4/ILT3 (TRX385)Cat. No. WA1792Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD85k/LILRB4/ILT3 (TRX385)Cat. No. WA1792
U-Blot® Research Grade Anti-Human CD85k/LILRB4/ILT3 (BND-35)Cat. No. WA1791
U-Blot® Research Grade Anti-Human CD85j/LILRB1/ILT2 (BND-22)Cat. No. WA1790
U-Blot® Research Grade Anti-Human CD85j/LILRB1 (AGEN1571)Cat. No. WA1789
U-Blot® Research Grade Anti-Human CD85d/LILRB2/ILT4 (ATG 032)Cat. No. WA1788
U-Blot® Research Grade Anti-Human CD85a/LILRB3 Antibody (7C5)Cat. No. WA1787
U-Blot® Research Grade Anti-Human CD83 (CBT004)Cat. No. WA1786
U-Blot® Research Grade Anti-Human CD75/ST6GAL1 (EBU-141 Tetra)Cat. No. WA1785
U-Blot® Research Grade Anti-Human CD73/NT5E Antibody (IPH5301)Cat. No. WA1784
U-Blot® Research Grade Anti-Human CD73/NT5E (Sym024)Cat. No. WA1783
U-Blot® Research Grade Anti-Human CD73/NT5E (PM 1015)Cat. No. WA1782
U-Blot® Research Grade Anti-Human CD73/NT5E (JAB-BX102)Cat. No. WA1781